235 related articles for article (PubMed ID: 20382698)
1. MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.
Li X; Mertens-Talcott SU; Zhang S; Kim K; Ball J; Safe S
Endocrinology; 2010 Jun; 151(6):2462-73. PubMed ID: 20382698
[TBL] [Abstract][Full Text] [Related]
2. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
Mertens-Talcott SU; Chintharlapalli S; Li X; Safe S
Cancer Res; 2007 Nov; 67(22):11001-11. PubMed ID: 18006846
[TBL] [Abstract][Full Text] [Related]
3. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.
Mertens-Talcott SU; Noratto GD; Li X; Angel-Morales G; Bertoldi MC; Safe S
Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor receptor-2 expression is down-regulated by 17beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteins.
Higgins KJ; Liu S; Abdelrahim M; Vanderlaag K; Liu X; Porter W; Metz R; Safe S
Mol Endocrinol; 2008 Feb; 22(2):388-402. PubMed ID: 18006642
[TBL] [Abstract][Full Text] [Related]
5. Ligand structure-dependent activation of estrogen receptor alpha/Sp by estrogens and xenoestrogens.
Wu F; Khan S; Wu Q; Barhoumi R; Burghardt R; Safe S
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):104-15. PubMed ID: 18400491
[TBL] [Abstract][Full Text] [Related]
6. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.
Pathi SS; Jutooru I; Chadalapaka G; Sreevalsan S; Anand S; Thatcher GR; Safe S
Mol Cancer Res; 2011 Feb; 9(2):195-202. PubMed ID: 21156786
[TBL] [Abstract][Full Text] [Related]
7. Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer.
Liu X; Jutooru I; Lei P; Kim K; Lee SO; Brents LK; Prather PL; Safe S
Mol Cancer Ther; 2012 Jul; 11(7):1421-31. PubMed ID: 22553354
[TBL] [Abstract][Full Text] [Related]
8. The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis.
Noratto GD; Jutooru I; Safe S; Angel-Morales G; Mertens-Talcott SU
Mol Nutr Food Res; 2013 Sep; 57(9):1638-48. PubMed ID: 23471840
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor receptor-2 expression is induced by 17beta-estradiol in ZR-75 breast cancer cells by estrogen receptor alpha/Sp proteins.
Higgins KJ; Liu S; Abdelrahim M; Yoon K; Vanderlaag K; Porter W; Metz RP; Safe S
Endocrinology; 2006 Jul; 147(7):3285-95. PubMed ID: 16574784
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation.
Banerjee N; Talcott S; Safe S; Mertens-Talcott SU
Breast Cancer Res Treat; 2012 Nov; 136(1):21-34. PubMed ID: 22941571
[TBL] [Abstract][Full Text] [Related]
11. GC-rich promoter elements maximally confers estrogen-induced transactivation of LRP16 gene through ERalpha/Sp1 interaction in MCF-7 cells.
Han WD; Si YL; Zhao YL; Li Q; Wu ZQ; Hao HJ; Song HJ
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):47-56. PubMed ID: 18206366
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
Chintharlapalli S; Papineni S; Abdelrahim M; Abudayyeh A; Jutooru I; Chadalapaka G; Wu F; Mertens-Talcott S; Vanderlaag K; Cho SD; Smith R; Safe S
Int J Cancer; 2009 Oct; 125(8):1965-74. PubMed ID: 19582879
[TBL] [Abstract][Full Text] [Related]
13. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.
Stoner M; Wormke M; Saville B; Samudio I; Qin C; Abdelrahim M; Safe S
Oncogene; 2004 Feb; 23(5):1052-63. PubMed ID: 14647449
[TBL] [Abstract][Full Text] [Related]
14. The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells.
Adams BD; Cowee DM; White BA
Mol Endocrinol; 2009 Aug; 23(8):1215-30. PubMed ID: 19423651
[TBL] [Abstract][Full Text] [Related]
15. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S
BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators.
Ljepoja B; GarcĂa-Roman J; Sommer AK; Wagner E; Roidl A
Breast; 2019 Feb; 43():31-38. PubMed ID: 30415143
[TBL] [Abstract][Full Text] [Related]
17. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.
Gandhy SU; Kim K; Larsen L; Rosengren RJ; Safe S
BMC Cancer; 2012 Nov; 12():564. PubMed ID: 23194063
[TBL] [Abstract][Full Text] [Related]
18. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
Ariazi EA; Brailoiu E; Yerrum S; Shupp HA; Slifker MJ; Cunliffe HE; Black MA; Donato AL; Arterburn JB; Oprea TI; Prossnitz ER; Dun NJ; Jordan VC
Cancer Res; 2010 Feb; 70(3):1184-94. PubMed ID: 20086172
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of Sp cellular transcription factors on viral promoter activation by varicella-zoster virus (VZV) IE62 protein.
Khalil MI; Ruyechan WT; Hay J; Arvin A
Virology; 2015 Nov; 485():47-57. PubMed ID: 26207799
[TBL] [Abstract][Full Text] [Related]
20. Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a.
Li W; Liu M; Xu YF; Feng Y; Che JP; Wang GC; Zheng JH
Oncol Rep; 2014 Jan; 31(1):117-24. PubMed ID: 24173369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]